Suppression of human monocyte tissue factor induction by red wine phenolics and synthetic derivatives of resveratrol

Thrombosis Research

Volumn 119, Issue 2, 2007, Pages 247-256

  Kaur, Gurjeet ^a   Roberti, Marinella ^b   Raul, Francis ^c   Pendurthi, Usha R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c IRCAD   (France)

Author keywords

Coronary heart diseases; Quercetin; Red wine phenolics; Resveratrol; Tissue factor

Indexed keywords

3,4',5 TRIMETHOXY 3' AMINOSTILBENE; 3,4',5 TRIMETHOXY 3' HYDROSTILBENE; 3,4',5 TRIMETHOXY 4' HYDROSTILBENE; 3,4',5 TRIMETHOXYSTILBENE; ANTICOAGULANT AGENT; CATECHIN; EPICATECHIN; LIPOPOLYSACCHARIDE; PHENOL DERIVATIVE; QUERCETIN; RESVERATROL; RUTOSIDE; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARDIOVASCULAR SYSTEM; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; ISCHEMIC HEART DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RED WINE; REGULATORY MECHANISM;

CELLS, CULTURED; DIETARY SUPPLEMENTS; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; PHENOL; QUERCETIN; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBOPLASTIN; WINE;

EID: 33751082988     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.01.020     Document Type: Article

References (50)

1. Rimm E.B., Giovannucci E.L., Willet W.C., Colditz G.A., Aschrio A., Rosner B., et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338 (1991) 464-468
2. Rimm E.B., Klatsky A., Grobbee D., and Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer wine or spirits. BMJ 312 (1996) 731-737
3. Szmitko P.E., and Verma S. Cardiology patient pages. Red wine and your heart. Circulation 111 (2005) e10-e11
4. Jackson R., Scragg R., and Beaglehole R. Alcohol consumption and risk of coronary heart disease. BMJ 303 (1991) 211-216
5. Renaud S., and De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1993) 1523-1526
6. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 8 (1997) 645-659
7. Frankel E.N., Kanner J., German J.B., Parks E., and Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341 (1993) 454-457
8. Frankel E.N., Waterhouse A.L., and Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 341 (1993) 1103-1104
9. Aviram M., and Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann N Y Acad Sci 957 (2002) 146-161
10. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., and Elwood P.C. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 55 (1992) 1012-1017
11. Bertelli A.A.E., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M., et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 17 (1995) 1-3
12. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., and Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis implications for protection against coronary heart disease. Clin Chim Acta 235 (1995) 207-219
13. Pendurthi U.R., Williams J.T., and Rao L.V.M. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol 19 (1999) 419-426
14. Pendurthi U.R., and Rao L.V.M. Effect of wine phenolics and stilbene analogues on tissue factor expression in endothelial cells. Thromb Res 106 (2002) 205-211
15. Di Santo A., Mezzetti A., Napoleone E., Di Tommaso R., Donati M.B., de Gaetano G., et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost 1 (2003) 1089-1095
16. Tsai S.-H., Lin-Shiau S.-Y., and Lin J.-K. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br J Pharmacol 126 (1999) 673-680
17. Bertelli A.A., Baccalini R., Battaglia E., Falchi M., and Ferrero M.E. Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 56 (2001) 613-616
18. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287 (2004) L774-L783
19. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., et al. Cancer chemopreventive activity of resveratrol a natural product derived from grapes. Science 275 (1997) 218-220
20. Jang M., and Pezzuto J.M. Effects of resveratrol on 12-O-tetrdecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 134 (1998) 81-89
21. Soleas G.J., Diamandis E.P., and Goldberg D.M. Wine as biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11 (1997) 287-313
22. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
23. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., et al. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 46 (2003) 3546-3554
24. Stivala L.A., Savio M., Carafoli F., Perucca P., Bianchi L., Maga G., et al. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276 (2001) 22586-22594
25. Schneider Y., Chabert P., Stutzmann J., Coelho D., Fougerousse A., Gosse F., et al. Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 107 (2003) 189-196
26. Rapaport S.I., and Rao L.V.M. The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost 74 (1995) 7-17
27. Drake T.A., Morrissey J.H., and Edgington T.S. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol 134 (1989) 1087-1097
28. Fleck R.A., Rao L.V.M., Rapaport S.I., and Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59 (1990) 421-437
29. Camerer E., Kolsto A.B., and Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 81 (1996) 1-41
30. Semeraro N., and Colucci M. Tissue factor in health and disease. Thromb Haemost 78 (1997) 759-764
31. Eilertsen K.E., and Osterud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 15 (2004) 521-538
32. Ardissino D., Merlini P.A., Arlens R., Coppola R., Bramucci E., Lucreziotti S., et al. Tissue factor in human coronary atherosclerotic plaques. Clin Chim Acta 291 (2000) 235-240
33. Ardissino D., Merlini P.A., Bauer K.A., Bramucci E., Ferrario M., Coppola R., et al. Thrombogenic potential of human coronary atherosclerotic plaques. Blood 98 (2001) 2726-2729
34. Marmur J.D., Thiruvikraman S.V., Fyfe B.S., Guha A., Sharma S.K., Ambrose J.A., et al. Identification of active tissue factor in human coronary atheroma. Circulation 94 (1996) 1226-1232
35. Taubman M.B., Fallon J.T., Schecter A.D., Giesen P., Mendlowitz M., Fyfe B.S., et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 78 (1997) 200-204
36. Ruf W., and Mueller B.M. Tissue factor signaling. Thromb Haemost 82 (1999) 175-182
37. Rao L.V.M., and Pendurthi U.R. Tissue factor-factor VIIa signaling. Arterioscler Thromb Vasc Biol 25 (2005) 47-56
38. Coughlin S.R. Protease-activated receptors in vascular biology. Thromb Haemost 86 (2001) 298-307
39. Ruf W. Protease-activated receptor signaling in the regulation of inflammation. Crit Care Med 32 (2004) S287-S292
40. Bertelli A., Bertelli A.A.E., Gozzini A., and Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 24 (1998) 133-138
41. Soleas G., Angelini M., Grass L., Diamandis E.P., and Goldberg D.M. Absorption of trans-resveratrol in rats. Methods Enzymol 335 (2001) 145-154
42. Goldberg D.M., Yan J., and Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36 (2003) 79-87
43. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65 (1983) 55-63
44. Goldberg D.M., Karumanchiri A., Yan J., Soleas G., Ng E., Waterhouse A.L., et al. A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Vitic 46 (1995) 159-165
45. Tedesco I., Russo M., Russo P., Iacomino G., Russo G.L., Carraturo A., et al. Antioxidant effect of red wine polyphenols on red blood cells. J Nutr Biochem 11 (2000) 114-119
46. Eilertsen K.E., and Osterud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 15 (2004) 521-538
47. Pedrielli P., and Skibsted L.H. Antioxidant synergy and regeneration effect of quercetin, (-)-epicatechin, and (+)-catechin on alpha-tocopherol in homogeneous solutions of peroxidating methyl linoleate. J Agric Food Chem 50 (2002) 7138-7144
48. Pignatelli P., Pulcinelli F.M., Celestini A., Lenti L., Ghiselli A., Gazzaniga P.P., et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 72 (2000) 1150-1155
49. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 78 (1997) 747-754
50. Pendurthi U.R., Meng F., Mackman N., and Rao L.V.M. Mechanism of resveratrol-mediated suppression of tissue factor gene expression. Thromb Haemost 87 (2002) 155-162